You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Targetable mutations

Showing 1 - 25 of 2,507
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Germany (FoundationOne®CDx and FoundationOne®Liquid)

Recruiting
  • Hepatocellular Cancer
  • +5 more
  • FoundationOne®CDx and FoundationOne®Liquid
  • Frankfurt, Hessen, Germany
  • +29 more
Aug 12, 2022

Breast Cancer Stage IV Trial in Nice, Villejuif (Alpelisib, Ribociclib)

Not yet recruiting
  • Breast Cancer Stage IV
  • Nice, France
  • +1 more
Nov 14, 2022

The PLATON Network

Recruiting
  • Hepatocellular Cancer
  • +5 more
    • Frankfurt, Hessen, Germany
    • +30 more
    Aug 12, 2022

    Refractory Solid Organ Malignancies Trial in Singapore (DRUID AI Program)

    Not yet recruiting
    • Refractory Solid Organ Malignancies
    • DRUID AI Program
    • Singapore, Singapore
      Department of Hematology-Oncology, National University Hospital
    Jan 30, 2023

    NSCLC Trial in Philadelphia (Telehealth)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Telehealth
    • Philadelphia, Pennsylvania
      Charu Aggarwal
    Mar 17, 2023

    Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +

    Recruiting
    • Metastatic Castration-Resistant Prostate Cancer
    • XmAb20717 + carboplatin + cabazitaxel
    • +2 more
    • Duarte, California
    • +9 more
    May 24, 2022

    Tissue and Blood Samples From Young Patients With Lung Cancer

    Completed
    • Non-small Cell Lung Cancer
    • Small Cell Lung Cancer
    • cytology specimen collection procedure
    • laboratory biomarker analysis
    • Los Angeles, California
    • +1 more
    Nov 16, 2021

    Potential Clinical Utilities of Circulating Tumor DNA in

    Not yet recruiting
    • Gastric Cancer
    • Circulating Tumor DNA (ctDNA)
      • (no location specified)
      Aug 21, 2022

      Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

      Not yet recruiting
      • Stage IV NSCLC
      • Houston, Texas
        Michael E. DeBakey VA Medical Center, Houston, TX
      Sep 28, 2023

      Cervical Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC Trial in Boston, Saint Louis (ITIL-168)

      Withdrawn
      • Cervical Cancer
      • +2 more
      • ITIL-168
      • (no location specified)
      Dec 16, 2022

      Neuroblastoma Precision Trial

      Active, not recruiting
      • Neuroblastoma
      • Gene panel sequencing of tumor specimens
      • Los Angeles, California
      • +10 more
      Feb 16, 2022

      Genes in Pancreatic Cancer for Better Treatment Selection

      Active, not recruiting
      • Carcinoma, Pancreatic Ductal
      • Molecular Profiling
      • Kingston, Ontario, Canada
      • +3 more
      Jan 25, 2023

      Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

      Not yet recruiting
      • Lung Cancer
      • +3 more
      • Kansas City, Kansas
      • +3 more
      May 12, 2023

      Vascular Ehlers-Danlos Syndrome Trial in Englewood (Enzastaurin, Placebo)

      Not yet recruiting
      • Vascular Ehlers-Danlos Syndrome
      • Englewood, Colorado
        Aytu BioPharma
      Jul 27, 2022

      Comprehensive Genomic Profiling Combined With Real Life Data of

      Active, not recruiting
      • Gallbladder Carcinoma
        • Frankfurt am Main, Germany
          Institut für Klinische Krebsforschung IKF GmbH
        Jan 31, 2022

        Osimertinib for NSCLC With Uncommon EGFR Mutations

        Enrolling by invitation
        • Carcinoma, Non-Small-Cell Lung
        • Genes, erbB-1
        • Ramat Gan, Israel
          Sheba Medical Centre
        Jun 14, 2022

        FGFR Gene Mutations in Tumor Tissue and Urine of Urothelial

        Not yet recruiting
        • Bladder Cancer
        • FGFR test
        • (no location specified)
        Apr 6, 2022

        Non Small Cell Lung Cancer Metastatic, Newly Diagnosed NSCLC, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States

        Not yet recruiting
        • Non Small Cell Lung Cancer Metastatic
        • +2 more
        • iNUDGE
        • Cherry Hill, New Jersey
        • +5 more
        May 9, 2023

        NSCLC Trial in United Kingdom (Afatinib)

        Active, not recruiting
        • Non-small Cell Lung Cancer
        • Aberdeen, United Kingdom
        • +6 more
        Feb 22, 2022

        Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

        Terminated
        • Neuroblastoma
        • Cancer
        • Biopsy
        • +12 more
        • Philadelphia, Pennsylvania
          The Children's Hospital of Philadelphia
        Jan 31, 2023

        Incidental Gallbladder Carcinoma-Permanent Platform Including

        Recruiting
        • Biliary Tract Cancer
        • Neoadjuvant, Adjuvant and 1st Line
          • Frankfurt, Germany
            Krankenhaus Nordwest GmbH
          Aug 3, 2022

          Solid Tumor, Lymphoma, Multiple Myeloma Trial in Winston-Salem (drug, other, diagnostic test)

          Recruiting
          • Solid Tumor
          • +4 more
          • Investigational Agent
          • +2 more
          • Winston-Salem, North Carolina
            Wake Forest Baptist Comprehensive Cancer Center
          Mar 4, 2022

          Non Small Cell Lung Cancer Trial in Cleveland (Liquid biopsy)

          Recruiting
          • Non Small Cell Lung Cancer
          • Liquid biopsy
          • Cleveland, Ohio
            Cleveland Clinic, Case Comprehensive Cancer Center
          Jan 6, 2022

          Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

          Recruiting
          • Acute Lymphoblastic Leukemia
          • Acute Lymphoblastic Lymphoma
          • Palo Alto, California
          • +6 more
          May 2, 2022

          Colorectal Cancer Trial in Stockholm, Västerås (pTTL)

          Recruiting
          • Colorectal Cancer
          • Stockholm, Sweden
          • +1 more
          Jun 7, 2023